Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q2 2024 Earnings Call Transcript
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q2 2024 Earnings Call Transcript July 23, 2024 Kiniksa Pharmaceuticals, Ltd. beats earnings expectations. Reported EPS is $0.1199, expectations were $-0.09. Operator: Good day and thank you for standing by. …